Sljedeći

Auto Play

The role of chemotherapy in Hodgkin lymphoma

0 Pogledi • 06/26/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Yago Nieto, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of chemotherapy in Hodgkin lymphoma (HL) treatment, which is typically employed in combination with novel agents such as brentuximab vedotin or checkpoint inhibitors. However, Prof. Nieto highlights that frail patients may require alternative chemotherapy-free approaches. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play